A randomized controlled pilot of Laurus nobilis Tea on inflammatory biomarkers
Phase 1
Recruiting
- Conditions
- Nutritional, Metabolic, EndocrineCardiology
- Registration Number
- PACTR202205585377035
- Lead Sponsor
- Metabolic Biophysics Applied Pharmacology Laboratory
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 62
Inclusion Criteria
No smoking
No vegetarian diet
No pregnancy
No consumption of medication or nutritional supplements
No any anti-inflammatory treatment (non-steroid anti-inflammatory drug, corticosteroid or other anti-inflammatory drug) No chronic pathologies (eg; cardiovascular diseases, diabetes-mellitus, arterial-hypertension, asthma, psychiatric disorders, gastrointestinal problems)
No food allergy
Exclusion Criteria
The absence during the second visit (ie; Day11 of the study)
The non-consumption of the Lnt or the placebo tea at least one time
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method